Program Oral Suspension for Small Cats and Kittens 133 mg

Ország: Egyesült Királyság

Nyelv: angol

Forrás: VMD (Veterinary Medicines Directorate)

Aktív összetevők:

Lufenuron

Beszerezhető a:

Elanco Europe Ltd

ATC-kód:

QP53BC01

INN (nemzetközi neve):

Lufenuron

Gyógyszerészeti forma:

Oral suspension

Recept típusa:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Terápiás csoport:

Cats

Terápiás terület:

Insect Growth Regulator

Engedélyezési státusz:

Expired

Engedély dátuma:

1993-07-08

Termékjellemzők

Revised: January 2016
AN: 01318/2015
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Program Oral Suspension for Small Cats and Kittens 133mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
mg/ampoule
Lufenuron
133
Excipients
Methyl parahydroxybenzoate
2.28
Propyl parahydroxybenzoate
0.57
For a full list of excipients see section 6.1
3.
PHARMACEUTICAL FORM;
Oral suspension
White aqueous suspension
4.
CLINICAL PARTICULARS:
4.1
TARGET SPECIES
Cats up to 4.5kg bodyweight
4.2
INDICATIONS FOR USE
For the prevention and lasting control of flea infestation in cats.
Effective
against the dominant flea species _Ctenocephalides felis and C. canis_
4.3
CONTRA-INDICATIONS
None
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
SPECIAL PRECAUTIONS FOR USE
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Revised: January 2016
AN: 01318/2015
Page 2 of 5
The product should not be used in kittens which are not fully weaned
or
kittens weighing less than 0.5Kg bodyweight.
II)
SPECIAL
PRECAUTIONS
TO
BE
TAKEN
BY
THE
PERSON
ADMINISTERING
THE
MEDICINAL PRODUCT TO ANIMALS
Avoid contact with skin and eyes. If contact occurs wash the affected
area
with clean water immediately. Seek medical attention if irritation
persists.
Wash hands after use.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
On very rare occasions, malaise, itching, vomiting or diarrhoea have
been
reported in cats following treatment with Program Suspension
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Can be used during pregnancy and lactation.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
The
minimum
recommended
dose
rate
is
30mg
a.i./kg/month.
This
is
achieved by giving cats and kittens up to 4.5kg the content of 1
ampoule .
To be fully effective the suspension MUST be administered together
with food.
Shake the ampoule prior to opening. The suspension should be added to
approximately half of the food ration. The rest of the